← Back to Search

Robotic Surgery

Robotic-Assisted Surgery for Lung Cancer and Thymoma

N/A
Waitlist Available
Led By David Rice, MD
Research Sponsored by Intuitive Surgical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical stage I or II primary lung cancer or other suspected lung malignancy; or benign lung disease requiring resection; primary tumor ≤ 5cm diameter (Lobectomy)
Masaoka clinical stage I or II thymoma; or thymectomy for myasthenia gravis; thymic mass ≤ 5 cm diameter (Thymectomy)
Must not have
Uncontrolled myasthenia gravis symptoms at the time of scheduled surgery (Thymectomy)
Clinical or radiological evidence of mediastinal or systemic metastatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-operative through the 30 days follow-up period
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the da Vinci SP surgical system to see if it is safe and effective for pulmonary lobectomy (removal of a lobe of the lung) and thymectomy (removal of the thymus) procedures.

Who is the study for?
Adults over 21 with a BMI ≤ 35, early-stage lung cancer or benign lung disease needing surgery, or thymoma/myasthenia gravis requiring thymectomy. Participants must consent to follow-ups for up to 5 years. Exclusions include bleeding disorders, heavy anticoagulant use, general anesthesia risks, prior thoracic treatments, short life expectancy (<6 months), pregnancy/breastfeeding, and recent immunotherapies.
What is being tested?
The trial is testing the safety and effectiveness of the da Vinci SP Surgical System for pulmonary lobectomy in patients with lung conditions and thymectomy in those with thymoma or myasthenia gravis. The study involves post-operative assessments at specific intervals after surgery.
What are the potential side effects?
While not explicitly listed here, potential side effects may include typical surgical risks such as pain at the incision site, infection risk from surgery, bleeding complications, reactions to anesthesia and possible damage to surrounding tissues during robotic-assisted procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My lung cancer is in an early stage (I or II) or I have a lung condition needing surgery, with the tumor being 5cm or smaller.
Select...
My thymoma is stage I or II, or I had a thymectomy for myasthenia gravis with a thymic mass ≤ 5 cm.
Select...
I am older than 21 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My myasthenia gravis symptoms are not under control before my thymectomy.
Select...
My cancer has spread to my chest area or other parts of my body.
Select...
I have had chemotherapy, immunotherapy, or radiation for my cancer.
Select...
I am currently taking medication to prevent blood clots.
Select...
I cannot undergo surgery or general anesthesia due to health risks.
Select...
My tumor needs surgery that may involve removing nearby structures.
Select...
My tumor needs surgery that may involve removing part of the chest wall or a large section of the lung.
Select...
I haven't had any major health issues like heart problems or severe infections in the last 6 months.
Select...
My surgery cannot be done with minimally invasive techniques.
Select...
I have had surgery or radiation therapy on the same side of my chest before.
Select...
I have been diagnosed with thymic carcinoma.
Select...
I have a condition that affects my blood's ability to clot.
Select...
I have had high blood pressure in the lungs and a lung surgery.
Select...
My tumor affects the airways and may need complex surgery.
Select...
I have had open-heart surgery before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intra-operative period
This trial's timeline: 3 weeks for screening, Varies for treatment, and intra-operative period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Event Rate
Rate of Conversion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SP Surgical SystemExperimental Treatment1 Intervention
Pulmonary lobectomy and thymectomy procedures will be performed by da Vinci SP Surgical System.

Find a Location

Who is running the clinical trial?

Intuitive SurgicalLead Sponsor
77 Previous Clinical Trials
50,529 Total Patients Enrolled
David Rice, MDPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
12 Total Patients Enrolled

Media Library

da Vinci SP Surgical System (Robotic Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT05150210 — N/A
Myasthenia Gravis Research Study Groups: SP Surgical System
Myasthenia Gravis Clinical Trial 2023: da Vinci SP Surgical System Highlights & Side Effects. Trial Name: NCT05150210 — N/A
da Vinci SP Surgical System (Robotic Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05150210 — N/A
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top